Phase 4 Study of Ranibizumab for the Treatment of Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Initial Fair Visual Acuity (RVOFV)

NCT01795209 Phase 4 TERMINATED

The purpose of this study is to determine the effect of ranibizumab for the treatment of macular edema (ME) secondary to branch retinal vein occlusion (BRVO) in patients with initial fair visual acuity.

Details

Lead sponsor	Seoul National University Bundang Hospital
Phase	Phase 4
Status	TERMINATED
Enrolment	19
Start date	2013-01
Completion	2017-12

Conditions

• Branch Retinal Vein Occlusion
• Macular Edema

Interventions

• Ranibizumab
• Sham injection
• Rescue laser

Primary outcomes

• Time to achieve an improvement of 10 or more Early Treatment Diabetic Retinopathy Study (ETDRS) letters in best-corrected visual acuity — 1 year

Countries

South Korea